Vinge advises Opus in connection with the takeover bid from Ograi

December 02, 2019 Capital Markets and Public M&A

Ograi BidCo AB has announced a public offer to the shareholders of Opus Group AB (publ) to tender all their shares in Opus to Ograi.

The offer values Opus at SEK 2,250 million.

The Vinge team is headed by Erik Sjöman and Anders Strid.


Vinge advises Calliditas Therapeutics in connection with Asahi Kasei Corporation’s public takeover offer

On 28 May 2024, Asahi Kasei Corporation announced a public takeover offer to the shareholders and holders of American Depositary Shares in Calliditas Therapeutics AB (publ) (”Calliditas Therapeutics”) to acquire all shares and American Depositary Shares (each representing two shares) in Calliditas Therapeutics.
May 28, 2024

Vinge has advised Alder on the establishment of Alder III

Vinge has advised Alder on the establishment of Alder's third and largest fund to date, Alder III.
May 27, 2024